ELMED Life Sciences raises $2.7 Mn in Series A funding
The Hyderabad-based company serves enterprise clients through a B2B model and has built a global presence, exporting its products to more than 18 countries.
Biotechnology startup ELMED Life Sciences has raised $2.7 million (around ₹25 crore) in a Series A funding round backed by AgriSURE Fund, managed by NABVENTURES.
The newly secured capital will be directed towards expanding production capabilities, advancing research initiatives, and strengthening the company’s distribution footprint across both domestic and international markets.
Founded by Pruthivin Reddy Madduri along with co-founder Nikhil Konkathi, ELMED Life Sciences operates in the microbiome space, developing probiotic-based solutions across sectors including animal health, agriculture, aquaculture, and human wellness.
Its offerings are designed to enhance productivity and sustainability through biological alternatives.
The Hyderabad-based company serves enterprise clients through a B2B model and has built a global presence, exporting its products to more than 18 countries. It is also planning to scale its manufacturing infrastructure in Hyderabad while increasing penetration in tier 2 and tier 3 markets.